A large-scale analysis of 59 adult cancers, using an allele-specific CNV calling method, revealed a prevalence of HLA class I LOH ranging from about 2 to 42% depending on the tumor type (~11% in sarcomas), and 85% of LOH involved all three HLA-A, -B and -C genes (49). The gene discussed is HLA-A; the disease is sarcoma.